Adenosine-elicited accumulation of cyclic AMP in brain slices: potentiation by agents which inhibit uptake of adenosine.

[1]  J. Fain.  Inhibition of adenosine cyclic 3', 5'-monophosphate accumulation in fat cells by adenosine, N6-(phenylisopropyl) adenosine, and related compounds. , 1973, Molecular pharmacology.

[2]  H. Bär,et al.  On the mechanism of adenyl cyclase inhibition by adenosine. , 1973, Canadian journal of physiology and pharmacology.

[3]  J. Daly,et al.  Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. II. The role of phosphodiesterase activity in the regulation of levels of cyclic adenosine 3',5'-monophosphate. , 1973, The Journal of biological chemistry.

[4]  J. Daly,et al.  Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. I. Formation of cyclic adenosine 3',5'-monophosphate from endogenous adenosine triphosphate and from radioactive adenosine triphosphate formed during a prior incubation with radioactive adenine. , 1973, The Journal of biological chemistry.

[5]  J. Daly,et al.  Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. 3. Formation, degradation, and reformation of cyclic adenosine 3',5'-monophosphate during sequential stimulations by biogenic amines and adenosine. , 1973, The Journal of biological chemistry.

[6]  R. Haslam,et al.  Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine. , 1972, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

[7]  W. Ward,et al.  Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells. , 1972, The Journal of biological chemistry.

[8]  C. Free,et al.  Effects of therapeutic agents on cyclic AMP metabolism in vitro. , 1972, Journal of pharmaceutical sciences.

[9]  J. Hanoune,et al.  Human brain and platelet cyclic adenosine 3',5'-monophosphate phosphodiesterases: different response to drugs. , 1972, Biochimica et biophysica acta.

[10]  J. Daly,et al.  Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 2. Effects of depolarizing agents, membrane stabilizers, phosphodiesterase inhibitors, and adenosine analogs. , 1972, Journal of medicinal chemistry.

[11]  H. Shimizu,et al.  ADENOSINE KINASE OF MAMMALIAN BRAIN: PARTIAL PURIFICATION AND ITS ROLE FOR THE UPTAKE OF ADENOSINE , 1972, Journal of neurochemistry.

[12]  J. Daly,et al.  Effect of depolarizing agents on accumulation of cyclic adenosine 3',5'-monophosphate in cerebral cortical slices. , 1972, European journal of pharmacology.

[13]  S. Takeyama,et al.  Inhibition of the protein kinase by adenine compounds: competitive inhibition with respect to ATP. , 1972, Biochemical and biophysical research communications.

[14]  R. Goldie,et al.  A species difference in the uptake of adenosine by heart. , 1971, Biochemical pharmacology.

[15]  M. Hakala,et al.  Adenosine kinase of sarcoma 180 cells N 6 -substituted adenosines as substrates and inhibitors. , 1971, Molecular pharmacology.

[16]  Huang Yc,et al.  Properties of a phosphodiesterase with high affinity for adenosine 3',5'-cyclic phosphate. , 1971 .

[17]  P. Gulyassy.  Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by adenine compounds. , 1971, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

[18]  J. Daly,et al.  Formation of cyclic adenosine 3',5'-monophosphate from adenosine in brain slices. , 1970, Biochimica et biophysica acta.

[19]  E. Roberts,et al.  Some properties of cyclic 3',5'-nucleotide phosphodiesterase of mouse brain: effects of imidazole-4-acetic acid, chlorpromazine, cyclic 3',5'-GMP, and other substances. , 1970, Brain research.

[20]  P. Greengard,et al.  Cyclic nucleotide-dependent protein kinases. V. Preparation and properties of adenosine 3',5'-monophosphate-dependent protein kinase from various bovine tissues. , 1970, Biochimica et biophysica acta.

[21]  D. Kessel,et al.  Effects of persantin on deoxycytidine transport by murine leukemia cells. , 1970, Biochimica et biophysica acta.

[22]  W. Rummel,et al.  Specificity of adenosine uptake into the heart and inhibition by dipyridamole. , 1970, European journal of pharmacology.

[23]  P. A. Watson,et al.  Inhibition of 3'5'-cyclic-AMP phosphodiesterase by some platelet aggregation inhibitors. , 1970, Biochemical pharmacology.

[24]  P. Greengard,et al.  Cyclic nucleotide-dependent protein kinases. 3. Purification and properties of adenosine 3',5'-monophosphate-dependent protein kinase from bovine brain. , 1969, The Journal of biological chemistry.

[25]  Plagemann Pg,et al.  Permeation as the rate-limiting step in the phosphorylation of uridine and choline and their incorporation into macromolecules by Novikoff hepatoma cells. Competitive inhibition by phenethyl alcohol, persantin, and adenosine. , 1969 .

[26]  B. Lindberg,et al.  Some properties of partially purified mammalian adenosine kinase. , 1967, The Journal of biological chemistry.

[27]  H. Klenow.  Further studies on the effect of deoxyadenosine on the accumulation of deoxyadenosine triphosphate and inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells in vitro. , 1962, Biochimica et biophysica acta.

[28]  J. Smith,et al.  The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. , 1971, The Biochemical journal.

[29]  A Sattin,et al.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. , 1970, Molecular pharmacology.

[30]  H. Klenow.  INHIBITION BY CORDYCEPIN AND 2-DEOXYGLUCOSE OF THE INCORPORATION OF (32P)ORTHOPHOSPHATE INTO THE NUCLEIC ACIDS OF EHRLICH ASCITES-TUMOR CELLS IN VITRO. , 1963, Biochimica et biophysica acta.